rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
12 Feb,15:52
659.60   18.00   2.81%
Volume 563,204
Prev close 641.60
Day's H/L (Rs.) 671.70 - 602.00
52wk H/L (Rs.) 891.50 - 490.50
Mkt Cap (Rs. Cr) 38,573.41
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
12 Feb,15:58
661.95   22.80   3.57%
Volume 6,840,095
Prev close 639.15
Day's H/L (Rs.) 672.90 - 601.55
52wk H/L (Rs.) 891.50 - 465.00
Turnover (Rs. Lacs) 43,602.87
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 3,265 market voices)   

140 Characters
  Cancel
Whatsap-77088-61772 - 17 hour(s) ago Know the right stocks to invest at right time . Get daily updates free for life long. Contact us on above whatsapp number
#Aurobindo-Pharma-Ltd
Reply   |   Share
Nidhi - 1 day(s) ago [SKB] The company has a team of well qualified analysts for the same. The company undertakes market research and consults the customers regarding the investment portfolio http://rediff.ly/4zmu2
#Aurobindo-Pharma-Ltd
Reply   |   Share
mayra jain - 1 day ago  Know call of the day
#Aurobindo-Pharma-Ltd
Reply   |  Share

Realtime news for Aurobindo Pharma Ltd. (See all 520 news)

14 February 2016, 18:04
Aurobindo Pharma gets final approval for Levofloxacin and other Top Corporate News - 2 day(s) ago
Aurobindo net surges by 39% in Q3 to Rs.535 cr, third interim of 70% - 4 day(s) ago
Aurobindo Pharma fixes record date for 3rd interim dividend - 4 day(s) ago
Glaxo, Auro Pharma and Dr Reddy's to report better topline in December quarter: Angel Broking - 5 day(s) ago
Aurobindo Pharma Ltd Board declares Third Interim Dividend of Rs. 0.70 - 4 day(s) ago

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Aurobindo Pharma receives USFDA Approval for Levofloxacin in Dextrose Injection - 3 day(s) ago
Result Presentation for December 31, 2015 - 4 day(s) ago

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
12.70
EPS (Rs.)
51.93
Sales (Rs. Cr)
2,175.93
Face Value (Rs.)
1
Net Profit
Margin (%)
 
18.73
Last Bonus
1:1
Last Dividend(%)
70
Return on
Average Equity
 
28.29

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Ajanta Pharma Ltd.
1,299.90
Alembic Pharmaceuticals Ltd.
590.80
Show more companies
Ajanta Pharma Ltd.
1,299.90
Alembic Pharmaceuticals Ltd.
590.80
Sanofi India Ltd.
4,153.50
Apollo Hospitals Enterprise Ltd.
1,426.05
Torrent Pharmaceuticals Ltd.
1,266.20
Divi's Laboratories Ltd.
1,018.95
Ipca Laboratories Ltd.
605.95
Fortis Healthcare Ltd.
155.35
Biocon Ltd.
442.90
Piramal Enterprises Ltd.
936.00
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close